Jose M. Zuniga
Research Subjects
Jose M. Zuniga has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
Julio Montaner
British Columbia Centre for Excellence in HIV/AIDS, BC, Canada
5 shared publications- Brian Gerard Williams
SACEMA
4 shared publications Mauro Schechter
4 shared publications- Reuben Granich
International Association of Providers of AIDS Care, Washington DC, USA
4 shared publications Suniti Solomon
4 shared publicationsChris Duncombe
Int Assoc Providers AIDS Care, Washington, DC 20006 USA
3 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by MDPI AG in Journal of Fast-Track Health
- Vol. 1 (1) , 1
Reimagining Health Through a Fast-Track Lens
With more than 21,000 open access academic journals in publication, a reasonable question at the launch of a journal is: “Why a new journal
- 22 July 2026
- Published by MDPI AG in Journal of Fast-Track Health
- Vol. 1 (1) , 1
Open AccessReimagining Health Through a Fast-Track Lens
With more than 21,000 open access academic journals in publication, a reasonable question at the launch of a journal is: “Why a new journal
- Open Access
- 1 January 2026
- Published by AOSIS in Southern African Journal of HIV Medicine
- Vol. 27 (1) , 8
Unlocking insights into HIV care: An in-depth analysis of key populations from the Fast-Track Cities Quality of Care survey in eThekwini, KwaZulu-Natal, South Africa
Background: Key populations experience disproportionate HIV burdens and structural barriers to care. Objective: To compare healthcare utilisation, HIV knowledge and barriers between key population groups (KPG) and non-key populations living with HIV in eThekwini, South Africa. Methods: We analysed the eThekwini Fast-Track Cities Quality of Care survey, a cross-sectional study across 30 high-HIV-burden facilities (April to July 2023). Adults living with HIV completed anonymous questionnaires; groups were compared using χ2 tests and multivariable logistic regression for partner notification. Results: Of 517 analysed participants, 128 (24.8%) were KPG. KPG participants were younger, more recently diagnosed (< 1 year: 9.4% vs 1.3%) and more often on antiretroviral therapy (ART) for 1–4 years (52.3% vs 33.4%), with similar daily adherence (~83%). KPG were more likely to access care via non-governmental organisations (NGOs; 23.4% vs 5.7%). Controls more often understood undetectable viral load (36.0% vs 21.9%) and that treatment benefits outweigh side effects (65.3% vs 42.9%). KPG more frequently reported undetectable viral load (55.5% vs 29.8%), more frequent screening for co-morbid conditions, and transport-cost barriers (15.6% vs 8.2%). In KPG, NGO care was associated with partner notification (adjusted odds ratio 18.06; 95% confidence interval 4.77–68.41). Conclusion: There are marked differences between KPG and adults with HIV in healthcare utilisation, HIV knowledge and structural barriers.
- 1 January 2026
- Published by AOSIS in Southern African Journal of HIV Medicine
- Vol. 27 (1) , 8
Open AccessUnlocking insights into HIV care: An in-depth analysis of key populations from the Fast-Track Cities Quality of Care survey in eThekwini, KwaZulu-Natal, South Africa
Background: Key populations experience disproportionate HIV burdens and structural barriers to care. Objective: To compare healthcare utilisation, HIV knowledge and barriers between key population groups (KPG) and non-key populations living with HIV in eThekwini, South Africa. Methods: We analysed the eThekwini Fast-Track Cities Quality of Care survey, a cross-sectional study across 30 high-HIV-burden facilities (April to July 2023). Adults living with HIV completed anonymous questionnaires; groups were compared using χ2 tests and multivariable logistic regression for partner notification. Results: Of 517 analysed participants, 128 (24.8%) were KPG. KPG participants were younger, more recently diagnosed (< 1 year: 9.4% vs 1.3%) and more often on antiretroviral therapy (ART) for 1–4 years (52.3% vs 33.4%), with similar daily adherence (~83%). KPG were more likely to access care via non-governmental organisations (NGOs; 23.4% vs 5.7%). Controls more often understood undetectable viral load (36.0% vs 21.9%) and that treatment benefits outweigh side effects (65.3% vs 42.9%). KPG more frequently reported undetectable viral load (55.5% vs 29.8%), more frequent screening for co-morbid conditions, and transport-cost barriers (15.6% vs 8.2%). In KPG, NGO care was associated with partner notification (adjusted odds ratio 18.06; 95% confidence interval 4.77–68.41). Conclusion: There are marked differences between KPG and adults with HIV in healthcare utilisation, HIV knowledge and structural barriers.
- Open Access
- 19 August 2025
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 24
Lack of Knowledge and Understanding of Undetectable Equals Untransmittable (U = U) Among People Living with HIV in the United States: Results from a Cross-Sectional Survey
Background: Launched in the United States (US) in 2016, the ‘undetectable equals untransmittable’ (U = U) message has revolutionized human immunodeficiency virus (HIV) management by affirming that individuals on antiretroviral therapy (ART) with undetectable viral loads (VL) cannot sexually transmit the virus. This study aimed to assess the knowledge and understanding of U = U and factors associated with the lack of understanding among people living with HIV (PLHIV) in the US. Methods: A cross-sectional, online survey was fielded from February to June 2022 in the US to PLHIV aged ≥18 years who were currently taking ART. Data on sociodemographic variables, HIV-related and general health characteristics were collected. The study assessed the knowledge and understanding of U = U and sources of U = U information. Multivariable analyses were used to identify the factors associated with the lack of U = U understanding among PLHIV. Results: A total of 781 PLHIV completed the study and were included in the analysis. Most participants were P = 0.006), recent HIV diagnosis (6 months to P = 0.018), suboptimal ART adherence (OR: 2.74, 95% CI: 1.88-4.01, P < 0.001), and lack HCP communication about the importance of an undetectable VL compared to those who understood U = U. Conclusion: The study highlights substantial gaps in understanding U = U among PLHIV and in HCP-patient communication. These findings underscore the need for targeted education for both PLHIV and HCPs, emphasizing the clinical implications and benefits of U = U in relation to HIV prevention.
- 19 August 2025
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 24
Open AccessLack of Knowledge and Understanding of Undetectable Equals Untransmittable (U = U) Among People Living with HIV in the United States: Results from a Cross-Sectional Survey
Background: Launched in the United States (US) in 2016, the ‘undetectable equals untransmittable’ (U = U) message has revolutionized human immunodeficiency virus (HIV) management by affirming that individuals on antiretroviral therapy (ART) with undetectable viral loads (VL) cannot sexually transmit the virus. This study aimed to assess the knowledge and understanding of U = U and factors associated with the lack of understanding among people living with HIV (PLHIV) in the US. Methods: A cross-sectional, online survey was fielded from February to June 2022 in the US to PLHIV aged ≥18 years who were currently taking ART. Data on sociodemographic variables, HIV-related and general health characteristics were collected. The study assessed the knowledge and understanding of U = U and sources of U = U information. Multivariable analyses were used to identify the factors associated with the lack of U = U understanding among PLHIV. Results: A total of 781 PLHIV completed the study and were included in the analysis. Most participants were P = 0.006), recent HIV diagnosis (6 months to P = 0.018), suboptimal ART adherence (OR: 2.74, 95% CI: 1.88-4.01, P < 0.001), and lack HCP communication about the importance of an undetectable VL compared to those who understood U = U. Conclusion: The study highlights substantial gaps in understanding U = U among PLHIV and in HCP-patient communication. These findings underscore the need for targeted education for both PLHIV and HCPs, emphasizing the clinical implications and benefits of U = U in relation to HIV prevention.
- Open Access
- 17 July 2025
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 24
Moving Beyond Viral Suppression: Poor Patient–Provider Communication and Its Impact on Healthcare Outcomes Among People Living With HIV in the United States
Background: While advancement in treatment have turned HIV into a manageable chronic condition achieving viral suppression, it has become imperative to focus on overall health and improving health-related quality of life of people living with HIV (PLHIV) beyond viral suppression. This study aimed to describe how PLHIV perceive and manage their overall health, factors influencing patient–provider communication, and the impact of poor patient–provider communication on health outcomes. Methods: This cross-sectional, online survey recruited HIV-positive adults in the United States between February 22 and June 2, 2022, via the Profiles Panel. Data on sociodemographic and health characteristics, and social determinants of health were collected. The study assessed how PLHIV view and manage their overall health by measuring self-rated overall health, Patient Activation Measure ® (PAM ® ), general and HIV-specific health locus of control (HLOC). Multivariable analyses were used to identify the barriers and unmet needs in the patient–primary HIV clinician communication. Results: Of the 781 PLHIV who completed the study, most participants were cisgender male (56.2%), non-Hispanic, White (51.5%), and <50 years old (67.0%). Over 90% of participants reported being virally suppressed or having an undetectable viral load. About one-third (31.5%) reported their overall health as either poor or fair. Participants were highly activated in managing their health with 58.0% at PAM level 3 and 33.3% at level 4 and had high scores across the dimensions of both general and HIV-specific HLOC. Overall, 18.2% of the participants reported suboptimal satisfaction and 16.8% reported facing difficulty in verbalizing their HIV-related health concerns with their primary HIV clinician. One-fourth of the participants reported “sometimes” or “never/rarely” discussing their HIV treatment medications with their primary HIV clinician. Furthermore, participants dissatisfied with their primary HIV clinician were twice as likely to self-report poor overall health (OR: 2.2, 95% CI: 1.38, 3.48). Conclusion: This study underscores the critical role of managing overall health by optimizing patient–provider relationships in influencing individual holistic well-being beyond viral suppression. Healthcare interventions should prioritize strategies to enhance patient communication and satisfaction, recognizing its profound impact on HIV and overall health outcomes.
- 17 July 2025
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 24
Open AccessMoving Beyond Viral Suppression: Poor Patient–Provider Communication and Its Impact on Healthcare Outcomes Among People Living With HIV in the United States
Background: While advancement in treatment have turned HIV into a manageable chronic condition achieving viral suppression, it has become imperative to focus on overall health and improving health-related quality of life of people living with HIV (PLHIV) beyond viral suppression. This study aimed to describe how PLHIV perceive and manage their overall health, factors influencing patient–provider communication, and the impact of poor patient–provider communication on health outcomes. Methods: This cross-sectional, online survey recruited HIV-positive adults in the United States between February 22 and June 2, 2022, via the Profiles Panel. Data on sociodemographic and health characteristics, and social determinants of health were collected. The study assessed how PLHIV view and manage their overall health by measuring self-rated overall health, Patient Activation Measure ® (PAM ® ), general and HIV-specific health locus of control (HLOC). Multivariable analyses were used to identify the barriers and unmet needs in the patient–primary HIV clinician communication. Results: Of the 781 PLHIV who completed the study, most participants were cisgender male (56.2%), non-Hispanic, White (51.5%), and <50 years old (67.0%). Over 90% of participants reported being virally suppressed or having an undetectable viral load. About one-third (31.5%) reported their overall health as either poor or fair. Participants were highly activated in managing their health with 58.0% at PAM level 3 and 33.3% at level 4 and had high scores across the dimensions of both general and HIV-specific HLOC. Overall, 18.2% of the participants reported suboptimal satisfaction and 16.8% reported facing difficulty in verbalizing their HIV-related health concerns with their primary HIV clinician. One-fourth of the participants reported “sometimes” or “never/rarely” discussing their HIV treatment medications with their primary HIV clinician. Furthermore, participants dissatisfied with their primary HIV clinician were twice as likely to self-report poor overall health (OR: 2.2, 95% CI: 1.38, 3.48). Conclusion: This study underscores the critical role of managing overall health by optimizing patient–provider relationships in influencing individual holistic well-being beyond viral suppression. Healthcare interventions should prioritize strategies to enhance patient communication and satisfaction, recognizing its profound impact on HIV and overall health outcomes.
- Open Access
- 13 April 2025
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 24
Uncompromising Scientific Integrity
- 13 April 2025
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 24
Open AccessUncompromising Scientific Integrity
- 20 July 2024
- Published by Elsevier in The Lancet HIV
- Vol. 11 (9) , e607-e648
IAPAC–Lancet HIV Commission on the future of urban HIV responses
- 20 July 2024
- Published by Elsevier in The Lancet HIV
- Vol. 11 (9) , e607-e648
IAPAC–Lancet HIV Commission on the future of urban HIV responses
- Open Access
- 1 January 2024
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 23
U = U: A Catalyst for Ending AIDS as a Public Health Threat
- 1 January 2024
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 23
Open AccessU = U: A Catalyst for Ending AIDS as a Public Health Threat
- 29 November 2021
- Published by Elsevier in The Lancet HIV
- Vol. 8 (12) , e732-e733
Charting a course for public health leadership by cities on HIV, tuberculosis, and viral hepatitis
- 29 November 2021
- Published by Elsevier in The Lancet HIV
- Vol. 8 (12) , e732-e733
Charting a course for public health leadership by cities on HIV, tuberculosis, and viral hepatitis
- 1 August 2021
- Published by Elsevier in The Lancet
- Vol. 398 (10302) , 741
The costs of PEPFAR's leadership vacuum
- 1 August 2021
- Published by Elsevier in The Lancet
- Vol. 398 (10302) , 741
The costs of PEPFAR's leadership vacuum
- Open Access
- 1 June 2021
- Published by Elsevier in The Lancet Public Health
- Vol. 6 (6) , e428-e433
A global public health convention for the 21st century
- 1 June 2021
- Published by Elsevier in The Lancet Public Health
- Vol. 6 (6) , e428-e433
Open AccessA global public health convention for the 21st century